Junlong Li

1.6k total citations
43 papers, 578 citations indexed

About

Junlong Li is a scholar working on Oncology, Physiology and Hematology. According to data from OpenAlex, Junlong Li has authored 43 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Physiology and 7 papers in Hematology. Recurrent topics in Junlong Li's work include Erythrocyte Function and Pathophysiology (6 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and CAR-T cell therapy research (4 papers). Junlong Li is often cited by papers focused on Erythrocyte Function and Pathophysiology (6 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and CAR-T cell therapy research (4 papers). Junlong Li collaborates with scholars based in China, United States and Canada. Junlong Li's co-authors include Keith A. Betts, April W. Armstrong, David Williams, James Signorovitch, Avani Joshi, Matthias Augustin, L. Puig, Martha Skup, Frederick L. Locke and Stephen J. Schuster and has published in prestigious journals such as Blood, American Journal of Epidemiology and Hypertension.

In The Last Decade

Junlong Li

39 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junlong Li China 12 239 164 114 90 62 43 578
Csilla Sipeky Hungary 18 187 0.8× 141 0.9× 29 0.3× 183 2.0× 8 0.1× 39 723
Barbara Brouwers Belgium 15 58 0.2× 341 2.1× 21 0.2× 165 1.8× 31 0.5× 32 718
Mels Hoogendoorn Netherlands 18 133 0.6× 304 1.9× 13 0.1× 139 1.5× 24 0.4× 75 887
Yingjun Ding China 11 496 2.1× 150 0.9× 19 0.2× 230 2.6× 5 0.1× 23 880
V. V. Yakusevich Russia 11 278 1.2× 75 0.5× 138 1.2× 28 0.3× 15 0.2× 23 581
N. Kramkimel France 15 103 0.4× 638 3.9× 57 0.5× 241 2.7× 3 0.0× 45 970
Aimin Jiang China 15 128 0.5× 316 1.9× 13 0.1× 201 2.2× 9 0.1× 52 717
Mirte Muller Netherlands 14 75 0.3× 666 4.1× 206 1.8× 76 0.8× 5 0.1× 29 893
Terry L. Ng Canada 17 67 0.3× 454 2.8× 24 0.2× 162 1.8× 31 0.5× 63 917
Matthew M. Goodman United States 14 81 0.3× 133 0.8× 131 1.1× 198 2.2× 6 0.1× 23 675

Countries citing papers authored by Junlong Li

Since Specialization
Citations

This map shows the geographic impact of Junlong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlong Li more than expected).

Fields of papers citing papers by Junlong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junlong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlong Li. The network helps show where Junlong Li may publish in the future.

Co-authorship network of co-authors of Junlong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Junlong Li. A scholar is included among the top collaborators of Junlong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junlong Li. Junlong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Zhaohui, et al.. (2025). Geniposide Stabilized Atherosclerosis Plaque by Induced M2 Polarization via PPARγ Signaling Pathway. Drug Design Development and Therapy. Volume 19. 8805–8821.
2.
Meng, Dejing, Junlong Li, Ran Zhao, et al.. (2025). Colorimetric-ratiometric fluorescence dual-mode visual detection of perfluorodecanoic acid in cosmetics based on ligand-regulated metal-optimized framework composite nanozyme. Chemical Engineering Science. 321. 122808–122808. 1 indexed citations
3.
Li, Junlong, Guiping Li, Shu Wang, et al.. (2025). Early acupuncture intervention strongly associates with improved swallowing recovery in post-stroke dysphagia: a multicenter real-world cohort study. Frontiers in Neurology. 16. 1553947–1553947.
4.
Zhou, Yijie, et al.. (2024). LINC00461 promotes bladder cancer cells EMT through miR-518b/HNRNPUL1 axis. Discover Oncology. 15(1). 419–419.
6.
Wang, Xiaolong, et al.. (2024). Geniposide ameliorates atherosclerosis by restoring lipophagy via suppressing PARP1/PI3K/AKT signaling pathway. Phytomedicine. 129. 155617–155617. 16 indexed citations
8.
Li, Junlong, et al.. (2023). Three-category colorectal lesion image automatic detection based on G-YOLOv8. 53. 8–8. 1 indexed citations
9.
Grace, Rachael F., Eduard J. van Beers, Joan‐Lluís Vives Corrons, et al.. (2023). The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design. BMJ Open. 13(3). e063605–e063605. 3 indexed citations
10.
Li, Junlong, et al.. (2022). Clinical Burden of Alpha- and Beta-Thalassemia Compared to Matched Controls in the Real-World Setting. Blood. 140(Supplement 1). 5362–5364. 3 indexed citations
11.
Kraus, Stephen R., Junlong Li, Rita M. Kristy, et al.. (2022). Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the United States. Journal of International Medical Research. 50(5). 3629159104–3629159104. 1 indexed citations
13.
Li, Junlong, Xiao Zhang, Xun Sun, et al.. (2022). A prognostication system based on clinical parameters and [18F]-FDG PET/CT in patients with newly diagnosed multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging. 50(6). 1665–1670. 7 indexed citations
14.
Pan, Shouhua, Si Li, Mingzhe Xiao, Dongsheng Chen, & Junlong Li. (2021). Significant benefit of everolimus in a patient with urothelial bladder cancer harboring a rare M1043I mutation of PIK3CA. Investigational New Drugs. 39(4). 1197–1199. 2 indexed citations
16.
Ma, Hui, Xinran Cao, Junlong Li, et al.. (2020). Pro-Renin Receptor Overexpression Promotes Angiotensin II–Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice. Human Gene Therapy. 31(11-12). 639–650. 9 indexed citations
17.
Ma, Hui, Yulin Wang, Junlong Li, et al.. (2020). AVE0991, a nonpeptide angiotensin-(1–7) mimic, inhibits angiotensin II–induced abdominal aortic aneurysm formation in apolipoprotein E knockout mice. Journal of Molecular Medicine. 98(4). 541–551. 11 indexed citations
18.
Li, Junlong, et al.. (2019). Acupuncture methods for acute migraine attack: a Bayesian network meta-analysis protocol. BMJ Open. 9(10). e031043–e031043. 3 indexed citations
20.
Gordon, Kenneth B., Keith A. Betts, Murali Sundaram, et al.. (2017). Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials. Journal of the American Academy of Dermatology. 77(6). 1030–1037. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026